Is Penumbra’s core scientific research authored by a fake person?

Quintessential is SHORT shares of Penumbra, inc (PEN)
Executive Summary
- Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
- Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
- Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
- Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
- QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
- Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
- QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
- Situation constitutes existential threat to Penumbra’s viability as a public company
